nodes	percent_of_prediction	percent_of_DWPC	metapath
Trihexyphenidyl—Parkinson's disease—Diphenhydramine—atopic dermatitis	0.494	1	CpDpCtD
Trihexyphenidyl—Cloperastine—Dimenhydrinate—atopic dermatitis	0.167	0.678	CrCrCtD
Trihexyphenidyl—CHRM2—Dimenhydrinate—atopic dermatitis	0.118	0.672	CbGbCtD
Trihexyphenidyl—Cloperastine—Diphenhydramine—atopic dermatitis	0.0793	0.322	CrCrCtD
Trihexyphenidyl—CHRM2—Diphenhydramine—atopic dermatitis	0.0578	0.328	CbGbCtD
Trihexyphenidyl—Intraocular pressure increased—Fluocinolone Acetonide—atopic dermatitis	0.00194	0.0267	CcSEcCtD
Trihexyphenidyl—Cognitive impairment—Hydrocortisone—atopic dermatitis	0.00155	0.0213	CcSEcCtD
Trihexyphenidyl—Ileus paralytic—Tacrolimus—atopic dermatitis	0.0015	0.0206	CcSEcCtD
Trihexyphenidyl—Cognitive impairment—Dexamethasone—atopic dermatitis	0.00133	0.0182	CcSEcCtD
Trihexyphenidyl—Cognitive impairment—Betamethasone—atopic dermatitis	0.00133	0.0182	CcSEcCtD
Trihexyphenidyl—Blindness—Tacrolimus—atopic dermatitis	0.00117	0.0161	CcSEcCtD
Trihexyphenidyl—Cognitive impairment—Prednisone—atopic dermatitis	0.00115	0.0159	CcSEcCtD
Trihexyphenidyl—Euphoric mood—Dimenhydrinate—atopic dermatitis	0.00106	0.0146	CcSEcCtD
Trihexyphenidyl—Euphoric mood—Diphenhydramine—atopic dermatitis	0.00106	0.0146	CcSEcCtD
Trihexyphenidyl—Intraocular pressure increased—Prednisolone—atopic dermatitis	0.000943	0.0129	CcSEcCtD
Trihexyphenidyl—Cognitive disorder—Hydrocortisone—atopic dermatitis	0.000936	0.0129	CcSEcCtD
Trihexyphenidyl—Intraocular pressure increased—Hydrocortisone—atopic dermatitis	0.000921	0.0126	CcSEcCtD
Trihexyphenidyl—Dry skin—Fluocinonide—atopic dermatitis	0.000911	0.0125	CcSEcCtD
Trihexyphenidyl—Cognitive disorder—Methylprednisolone—atopic dermatitis	0.00088	0.0121	CcSEcCtD
Trihexyphenidyl—Intraocular pressure increased—Triamcinolone—atopic dermatitis	0.000867	0.0119	CcSEcCtD
Trihexyphenidyl—Intraocular pressure increased—Methylprednisolone—atopic dermatitis	0.000865	0.0119	CcSEcCtD
Trihexyphenidyl—Hyperkinesia—Loratadine—atopic dermatitis	0.000829	0.0114	CcSEcCtD
Trihexyphenidyl—Cognitive disorder—Dexamethasone—atopic dermatitis	0.0008	0.011	CcSEcCtD
Trihexyphenidyl—Cognitive disorder—Betamethasone—atopic dermatitis	0.0008	0.011	CcSEcCtD
Trihexyphenidyl—Intraocular pressure increased—Dexamethasone—atopic dermatitis	0.000787	0.0108	CcSEcCtD
Trihexyphenidyl—Intraocular pressure increased—Betamethasone—atopic dermatitis	0.000787	0.0108	CcSEcCtD
Trihexyphenidyl—Blindness—Hydrocortisone—atopic dermatitis	0.000731	0.01	CcSEcCtD
Trihexyphenidyl—Cognitive disorder—Prednisone—atopic dermatitis	0.000697	0.00957	CcSEcCtD
Trihexyphenidyl—Drowsiness—Diphenhydramine—atopic dermatitis	0.00069	0.00948	CcSEcCtD
Trihexyphenidyl—Drowsiness—Dimenhydrinate—atopic dermatitis	0.00069	0.00948	CcSEcCtD
Trihexyphenidyl—Blindness—Triamcinolone—atopic dermatitis	0.000689	0.00946	CcSEcCtD
Trihexyphenidyl—Blindness—Methylprednisolone—atopic dermatitis	0.000687	0.00944	CcSEcCtD
Trihexyphenidyl—Intraocular pressure increased—Prednisone—atopic dermatitis	0.000685	0.00941	CcSEcCtD
Trihexyphenidyl—Blindness—Dexamethasone—atopic dermatitis	0.000625	0.00858	CcSEcCtD
Trihexyphenidyl—Blindness—Betamethasone—atopic dermatitis	0.000625	0.00858	CcSEcCtD
Trihexyphenidyl—Delusion—Hydrocortisone—atopic dermatitis	0.000572	0.00786	CcSEcCtD
Trihexyphenidyl—Delusion—Methylprednisolone—atopic dermatitis	0.000538	0.00738	CcSEcCtD
Trihexyphenidyl—Drowsiness—Loratadine—atopic dermatitis	0.000532	0.0073	CcSEcCtD
Trihexyphenidyl—Tension—Dimenhydrinate—atopic dermatitis	0.000529	0.00727	CcSEcCtD
Trihexyphenidyl—Tension—Diphenhydramine—atopic dermatitis	0.000529	0.00727	CcSEcCtD
Trihexyphenidyl—Nervousness—Dimenhydrinate—atopic dermatitis	0.000524	0.0072	CcSEcCtD
Trihexyphenidyl—Nervousness—Diphenhydramine—atopic dermatitis	0.000524	0.0072	CcSEcCtD
Trihexyphenidyl—Mydriasis—Prednisolone—atopic dermatitis	0.00052	0.00714	CcSEcCtD
Trihexyphenidyl—Vision blurred—Diphenhydramine—atopic dermatitis	0.000508	0.00698	CcSEcCtD
Trihexyphenidyl—Vision blurred—Dimenhydrinate—atopic dermatitis	0.000508	0.00698	CcSEcCtD
Trihexyphenidyl—Agitation—Dimenhydrinate—atopic dermatitis	0.000496	0.00681	CcSEcCtD
Trihexyphenidyl—Agitation—Diphenhydramine—atopic dermatitis	0.000496	0.00681	CcSEcCtD
Trihexyphenidyl—Delusion—Dexamethasone—atopic dermatitis	0.000489	0.00671	CcSEcCtD
Trihexyphenidyl—Delusion—Betamethasone—atopic dermatitis	0.000489	0.00671	CcSEcCtD
Trihexyphenidyl—Psychotic disorder—Tacrolimus—atopic dermatitis	0.00046	0.00632	CcSEcCtD
Trihexyphenidyl—Confusional state—Dimenhydrinate—atopic dermatitis	0.000444	0.0061	CcSEcCtD
Trihexyphenidyl—Confusional state—Diphenhydramine—atopic dermatitis	0.000444	0.0061	CcSEcCtD
Trihexyphenidyl—Dry skin—Tacrolimus—atopic dermatitis	0.000432	0.00593	CcSEcCtD
Trihexyphenidyl—Tachycardia—Dimenhydrinate—atopic dermatitis	0.00043	0.0059	CcSEcCtD
Trihexyphenidyl—Tachycardia—Diphenhydramine—atopic dermatitis	0.00043	0.0059	CcSEcCtD
Trihexyphenidyl—Delusion—Prednisone—atopic dermatitis	0.000426	0.00585	CcSEcCtD
Trihexyphenidyl—Tension—Loratadine—atopic dermatitis	0.000408	0.0056	CcSEcCtD
Trihexyphenidyl—Nervousness—Loratadine—atopic dermatitis	0.000404	0.00554	CcSEcCtD
Trihexyphenidyl—Somnolence—Diphenhydramine—atopic dermatitis	0.000391	0.00538	CcSEcCtD
Trihexyphenidyl—Somnolence—Dimenhydrinate—atopic dermatitis	0.000391	0.00538	CcSEcCtD
Trihexyphenidyl—Memory impairment—Prednisone—atopic dermatitis	0.000384	0.00527	CcSEcCtD
Trihexyphenidyl—Agitation—Loratadine—atopic dermatitis	0.000382	0.00524	CcSEcCtD
Trihexyphenidyl—Rash—Desonide—atopic dermatitis	0.00038	0.00522	CcSEcCtD
Trihexyphenidyl—Dermatitis—Desonide—atopic dermatitis	0.00038	0.00521	CcSEcCtD
Trihexyphenidyl—Headache—Desonide—atopic dermatitis	0.000378	0.00519	CcSEcCtD
Trihexyphenidyl—Constipation—Dimenhydrinate—atopic dermatitis	0.000377	0.00517	CcSEcCtD
Trihexyphenidyl—Constipation—Diphenhydramine—atopic dermatitis	0.000377	0.00517	CcSEcCtD
Trihexyphenidyl—Weight decreased—Tacrolimus—atopic dermatitis	0.000369	0.00506	CcSEcCtD
Trihexyphenidyl—Constipation—Pimecrolimus—atopic dermatitis	0.000364	0.005	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Dimenhydrinate—atopic dermatitis	0.000363	0.00498	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Diphenhydramine—atopic dermatitis	0.000363	0.00498	CcSEcCtD
Trihexyphenidyl—Euphoric mood—Prednisolone—atopic dermatitis	0.000356	0.00489	CcSEcCtD
Trihexyphenidyl—Vision blurred—Fluocinolone Acetonide—atopic dermatitis	0.000352	0.00483	CcSEcCtD
Trihexyphenidyl—Euphoric mood—Hydrocortisone—atopic dermatitis	0.000348	0.00478	CcSEcCtD
Trihexyphenidyl—Tachycardia—Loratadine—atopic dermatitis	0.000331	0.00455	CcSEcCtD
Trihexyphenidyl—Euphoric mood—Triamcinolone—atopic dermatitis	0.000328	0.0045	CcSEcCtD
Trihexyphenidyl—Euphoric mood—Methylprednisolone—atopic dermatitis	0.000327	0.00449	CcSEcCtD
Trihexyphenidyl—Hallucination—Tacrolimus—atopic dermatitis	0.000324	0.00446	CcSEcCtD
Trihexyphenidyl—Dizziness—Fluocinonide—atopic dermatitis	0.000323	0.00444	CcSEcCtD
Trihexyphenidyl—Asthenia—Dimenhydrinate—atopic dermatitis	0.000316	0.00434	CcSEcCtD
Trihexyphenidyl—Asthenia—Diphenhydramine—atopic dermatitis	0.000316	0.00434	CcSEcCtD
Trihexyphenidyl—Rash—Fluocinonide—atopic dermatitis	0.000308	0.00423	CcSEcCtD
Trihexyphenidyl—Dermatitis—Fluocinonide—atopic dermatitis	0.000308	0.00423	CcSEcCtD
Trihexyphenidyl—Headache—Fluocinonide—atopic dermatitis	0.000306	0.0042	CcSEcCtD
Trihexyphenidyl—Somnolence—Loratadine—atopic dermatitis	0.000301	0.00414	CcSEcCtD
Trihexyphenidyl—Euphoric mood—Dexamethasone—atopic dermatitis	0.000297	0.00408	CcSEcCtD
Trihexyphenidyl—Euphoric mood—Betamethasone—atopic dermatitis	0.000297	0.00408	CcSEcCtD
Trihexyphenidyl—Dizziness—Dimenhydrinate—atopic dermatitis	0.000291	0.004	CcSEcCtD
Trihexyphenidyl—Dizziness—Diphenhydramine—atopic dermatitis	0.000291	0.004	CcSEcCtD
Trihexyphenidyl—Constipation—Loratadine—atopic dermatitis	0.00029	0.00398	CcSEcCtD
Trihexyphenidyl—Psychotic disorder—Hydrocortisone—atopic dermatitis	0.000287	0.00394	CcSEcCtD
Trihexyphenidyl—Vomiting—Dimenhydrinate—atopic dermatitis	0.00028	0.00385	CcSEcCtD
Trihexyphenidyl—Vomiting—Diphenhydramine—atopic dermatitis	0.00028	0.00385	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Loratadine—atopic dermatitis	0.000279	0.00384	CcSEcCtD
Trihexyphenidyl—Tension—Tacrolimus—atopic dermatitis	0.000278	0.00383	CcSEcCtD
Trihexyphenidyl—Rash—Dimenhydrinate—atopic dermatitis	0.000278	0.00381	CcSEcCtD
Trihexyphenidyl—Rash—Diphenhydramine—atopic dermatitis	0.000278	0.00381	CcSEcCtD
Trihexyphenidyl—Dermatitis—Dimenhydrinate—atopic dermatitis	0.000277	0.00381	CcSEcCtD
Trihexyphenidyl—Dermatitis—Diphenhydramine—atopic dermatitis	0.000277	0.00381	CcSEcCtD
Trihexyphenidyl—Dry skin—Prednisolone—atopic dermatitis	0.000276	0.00379	CcSEcCtD
Trihexyphenidyl—Headache—Diphenhydramine—atopic dermatitis	0.000276	0.00379	CcSEcCtD
Trihexyphenidyl—Headache—Dimenhydrinate—atopic dermatitis	0.000276	0.00379	CcSEcCtD
Trihexyphenidyl—Nervousness—Tacrolimus—atopic dermatitis	0.000276	0.00379	CcSEcCtD
Trihexyphenidyl—Vomiting—Pimecrolimus—atopic dermatitis	0.000271	0.00372	CcSEcCtD
Trihexyphenidyl—Psychotic disorder—Methylprednisolone—atopic dermatitis	0.00027	0.0037	CcSEcCtD
Trihexyphenidyl—Dry skin—Hydrocortisone—atopic dermatitis	0.000269	0.0037	CcSEcCtD
Trihexyphenidyl—Rash—Pimecrolimus—atopic dermatitis	0.000268	0.00369	CcSEcCtD
Trihexyphenidyl—Dermatitis—Pimecrolimus—atopic dermatitis	0.000268	0.00368	CcSEcCtD
Trihexyphenidyl—Vision blurred—Tacrolimus—atopic dermatitis	0.000267	0.00367	CcSEcCtD
Trihexyphenidyl—Headache—Pimecrolimus—atopic dermatitis	0.000267	0.00366	CcSEcCtD
Trihexyphenidyl—Hyperkinesia—Prednisone—atopic dermatitis	0.000263	0.00361	CcSEcCtD
Trihexyphenidyl—Nausea—Dimenhydrinate—atopic dermatitis	0.000262	0.00359	CcSEcCtD
Trihexyphenidyl—Nausea—Diphenhydramine—atopic dermatitis	0.000262	0.00359	CcSEcCtD
Trihexyphenidyl—Agitation—Tacrolimus—atopic dermatitis	0.000261	0.00358	CcSEcCtD
Trihexyphenidyl—Euphoric mood—Prednisone—atopic dermatitis	0.000259	0.00356	CcSEcCtD
Trihexyphenidyl—Nausea—Pimecrolimus—atopic dermatitis	0.000253	0.00347	CcSEcCtD
Trihexyphenidyl—Psychotic disorder—Betamethasone—atopic dermatitis	0.000245	0.00337	CcSEcCtD
Trihexyphenidyl—Psychotic disorder—Dexamethasone—atopic dermatitis	0.000245	0.00337	CcSEcCtD
Trihexyphenidyl—Asthenia—Loratadine—atopic dermatitis	0.000243	0.00334	CcSEcCtD
Trihexyphenidyl—Confusional state—Tacrolimus—atopic dermatitis	0.000234	0.00321	CcSEcCtD
Trihexyphenidyl—Dry skin—Betamethasone—atopic dermatitis	0.00023	0.00316	CcSEcCtD
Trihexyphenidyl—Dry skin—Dexamethasone—atopic dermatitis	0.00023	0.00316	CcSEcCtD
Trihexyphenidyl—Weight decreased—Hydrocortisone—atopic dermatitis	0.00023	0.00316	CcSEcCtD
Trihexyphenidyl—Tachycardia—Tacrolimus—atopic dermatitis	0.000226	0.0031	CcSEcCtD
Trihexyphenidyl—Dizziness—Loratadine—atopic dermatitis	0.000224	0.00308	CcSEcCtD
Trihexyphenidyl—Vomiting—Loratadine—atopic dermatitis	0.000216	0.00296	CcSEcCtD
Trihexyphenidyl—Rash—Loratadine—atopic dermatitis	0.000214	0.00294	CcSEcCtD
Trihexyphenidyl—Psychotic disorder—Prednisone—atopic dermatitis	0.000214	0.00293	CcSEcCtD
Trihexyphenidyl—Dermatitis—Loratadine—atopic dermatitis	0.000214	0.00293	CcSEcCtD
Trihexyphenidyl—Headache—Loratadine—atopic dermatitis	0.000212	0.00292	CcSEcCtD
Trihexyphenidyl—Asthenia—Mometasone—atopic dermatitis	0.000209	0.00287	CcSEcCtD
Trihexyphenidyl—Somnolence—Tacrolimus—atopic dermatitis	0.000206	0.00283	CcSEcCtD
Trihexyphenidyl—Hallucination—Hydrocortisone—atopic dermatitis	0.000202	0.00278	CcSEcCtD
Trihexyphenidyl—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.000202	0.00277	CcSEcCtD
Trihexyphenidyl—Nausea—Loratadine—atopic dermatitis	0.000201	0.00277	CcSEcCtD
Trihexyphenidyl—Dry skin—Prednisone—atopic dermatitis	0.0002	0.00275	CcSEcCtD
Trihexyphenidyl—Constipation—Tacrolimus—atopic dermatitis	0.000198	0.00272	CcSEcCtD
Trihexyphenidyl—Weight decreased—Betamethasone—atopic dermatitis	0.000196	0.0027	CcSEcCtD
Trihexyphenidyl—Weight decreased—Dexamethasone—atopic dermatitis	0.000196	0.0027	CcSEcCtD
Trihexyphenidyl—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000194	0.00266	CcSEcCtD
Trihexyphenidyl—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000192	0.00264	CcSEcCtD
Trihexyphenidyl—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000192	0.00264	CcSEcCtD
Trihexyphenidyl—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000191	0.00262	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Tacrolimus—atopic dermatitis	0.000191	0.00262	CcSEcCtD
Trihexyphenidyl—Hallucination—Methylprednisolone—atopic dermatitis	0.00019	0.00261	CcSEcCtD
Trihexyphenidyl—Vomiting—Mometasone—atopic dermatitis	0.000185	0.00254	CcSEcCtD
Trihexyphenidyl—Rash—Mometasone—atopic dermatitis	0.000183	0.00252	CcSEcCtD
Trihexyphenidyl—Dermatitis—Mometasone—atopic dermatitis	0.000183	0.00252	CcSEcCtD
Trihexyphenidyl—Headache—Mometasone—atopic dermatitis	0.000182	0.0025	CcSEcCtD
Trihexyphenidyl—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000181	0.00249	CcSEcCtD
Trihexyphenidyl—Hallucination—Betamethasone—atopic dermatitis	0.000173	0.00237	CcSEcCtD
Trihexyphenidyl—Hallucination—Dexamethasone—atopic dermatitis	0.000173	0.00237	CcSEcCtD
Trihexyphenidyl—Nausea—Mometasone—atopic dermatitis	0.000173	0.00237	CcSEcCtD
Trihexyphenidyl—Weight decreased—Prednisone—atopic dermatitis	0.000171	0.00235	CcSEcCtD
Trihexyphenidyl—Vision blurred—Prednisolone—atopic dermatitis	0.000171	0.00235	CcSEcCtD
Trihexyphenidyl—Asthenia—Tacrolimus—atopic dermatitis	0.000166	0.00228	CcSEcCtD
Trihexyphenidyl—Dizziness—Tacrolimus—atopic dermatitis	0.000153	0.0021	CcSEcCtD
Trihexyphenidyl—Hallucination—Prednisone—atopic dermatitis	0.000151	0.00207	CcSEcCtD
Trihexyphenidyl—Vomiting—Tacrolimus—atopic dermatitis	0.000147	0.00202	CcSEcCtD
Trihexyphenidyl—Rash—Tacrolimus—atopic dermatitis	0.000146	0.00201	CcSEcCtD
Trihexyphenidyl—Dermatitis—Tacrolimus—atopic dermatitis	0.000146	0.002	CcSEcCtD
Trihexyphenidyl—Headache—Tacrolimus—atopic dermatitis	0.000145	0.00199	CcSEcCtD
Trihexyphenidyl—Tachycardia—Prednisolone—atopic dermatitis	0.000144	0.00198	CcSEcCtD
Trihexyphenidyl—Tachycardia—Hydrocortisone—atopic dermatitis	0.000141	0.00194	CcSEcCtD
Trihexyphenidyl—Nausea—Tacrolimus—atopic dermatitis	0.000138	0.00189	CcSEcCtD
Trihexyphenidyl—Confusional state—Methylprednisolone—atopic dermatitis	0.000137	0.00188	CcSEcCtD
Trihexyphenidyl—Tachycardia—Triamcinolone—atopic dermatitis	0.000133	0.00182	CcSEcCtD
Trihexyphenidyl—Tachycardia—Methylprednisolone—atopic dermatitis	0.000132	0.00182	CcSEcCtD
Trihexyphenidyl—Vision blurred—Prednisone—atopic dermatitis	0.000124	0.00171	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Prednisolone—atopic dermatitis	0.000122	0.00167	CcSEcCtD
Trihexyphenidyl—Agitation—Prednisone—atopic dermatitis	0.000121	0.00166	CcSEcCtD
Trihexyphenidyl—Tachycardia—Dexamethasone—atopic dermatitis	0.00012	0.00165	CcSEcCtD
Trihexyphenidyl—Tachycardia—Betamethasone—atopic dermatitis	0.00012	0.00165	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000119	0.00164	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000112	0.00154	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000112	0.00154	CcSEcCtD
Trihexyphenidyl—Tachycardia—Prednisone—atopic dermatitis	0.000105	0.00144	CcSEcCtD
Trihexyphenidyl—Asthenia—Hydrocortisone—atopic dermatitis	0.000104	0.00142	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000102	0.0014	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Betamethasone—atopic dermatitis	0.000102	0.0014	CcSEcCtD
Trihexyphenidyl—Dizziness—Prednisolone—atopic dermatitis	9.78e-05	0.00134	CcSEcCtD
Trihexyphenidyl—Asthenia—Triamcinolone—atopic dermatitis	9.76e-05	0.00134	CcSEcCtD
Trihexyphenidyl—Asthenia—Methylprednisolone—atopic dermatitis	9.74e-05	0.00134	CcSEcCtD
Trihexyphenidyl—Dizziness—Hydrocortisone—atopic dermatitis	9.55e-05	0.00131	CcSEcCtD
Trihexyphenidyl—Rash—Prednisolone—atopic dermatitis	9.33e-05	0.00128	CcSEcCtD
Trihexyphenidyl—Dermatitis—Prednisolone—atopic dermatitis	9.32e-05	0.00128	CcSEcCtD
Trihexyphenidyl—Headache—Prednisolone—atopic dermatitis	9.27e-05	0.00127	CcSEcCtD
Trihexyphenidyl—Constipation—Prednisone—atopic dermatitis	9.19e-05	0.00126	CcSEcCtD
Trihexyphenidyl—Vomiting—Hydrocortisone—atopic dermatitis	9.19e-05	0.00126	CcSEcCtD
Trihexyphenidyl—Rash—Hydrocortisone—atopic dermatitis	9.11e-05	0.00125	CcSEcCtD
Trihexyphenidyl—Dermatitis—Hydrocortisone—atopic dermatitis	9.1e-05	0.00125	CcSEcCtD
Trihexyphenidyl—Headache—Hydrocortisone—atopic dermatitis	9.05e-05	0.00124	CcSEcCtD
Trihexyphenidyl—Dizziness—Triamcinolone—atopic dermatitis	9e-05	0.00124	CcSEcCtD
Trihexyphenidyl—Dizziness—Methylprednisolone—atopic dermatitis	8.98e-05	0.00123	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Prednisone—atopic dermatitis	8.86e-05	0.00122	CcSEcCtD
Trihexyphenidyl—Asthenia—Betamethasone—atopic dermatitis	8.86e-05	0.00122	CcSEcCtD
Trihexyphenidyl—Asthenia—Dexamethasone—atopic dermatitis	8.86e-05	0.00122	CcSEcCtD
Trihexyphenidyl—Nausea—Prednisolone—atopic dermatitis	8.79e-05	0.00121	CcSEcCtD
Trihexyphenidyl—Vomiting—Triamcinolone—atopic dermatitis	8.65e-05	0.00119	CcSEcCtD
Trihexyphenidyl—Vomiting—Methylprednisolone—atopic dermatitis	8.63e-05	0.00119	CcSEcCtD
Trihexyphenidyl—Nausea—Hydrocortisone—atopic dermatitis	8.58e-05	0.00118	CcSEcCtD
Trihexyphenidyl—Rash—Triamcinolone—atopic dermatitis	8.58e-05	0.00118	CcSEcCtD
Trihexyphenidyl—Dermatitis—Triamcinolone—atopic dermatitis	8.57e-05	0.00118	CcSEcCtD
Trihexyphenidyl—Rash—Methylprednisolone—atopic dermatitis	8.56e-05	0.00118	CcSEcCtD
Trihexyphenidyl—Dermatitis—Methylprednisolone—atopic dermatitis	8.55e-05	0.00117	CcSEcCtD
Trihexyphenidyl—Headache—Triamcinolone—atopic dermatitis	8.52e-05	0.00117	CcSEcCtD
Trihexyphenidyl—Headache—Methylprednisolone—atopic dermatitis	8.5e-05	0.00117	CcSEcCtD
Trihexyphenidyl—Dizziness—Betamethasone—atopic dermatitis	8.16e-05	0.00112	CcSEcCtD
Trihexyphenidyl—Dizziness—Dexamethasone—atopic dermatitis	8.16e-05	0.00112	CcSEcCtD
Trihexyphenidyl—Nausea—Triamcinolone—atopic dermatitis	8.08e-05	0.00111	CcSEcCtD
Trihexyphenidyl—Nausea—Methylprednisolone—atopic dermatitis	8.06e-05	0.00111	CcSEcCtD
Trihexyphenidyl—Vomiting—Betamethasone—atopic dermatitis	7.85e-05	0.00108	CcSEcCtD
Trihexyphenidyl—Vomiting—Dexamethasone—atopic dermatitis	7.85e-05	0.00108	CcSEcCtD
Trihexyphenidyl—Rash—Dexamethasone—atopic dermatitis	7.78e-05	0.00107	CcSEcCtD
Trihexyphenidyl—Rash—Betamethasone—atopic dermatitis	7.78e-05	0.00107	CcSEcCtD
Trihexyphenidyl—Dermatitis—Betamethasone—atopic dermatitis	7.78e-05	0.00107	CcSEcCtD
Trihexyphenidyl—Dermatitis—Dexamethasone—atopic dermatitis	7.78e-05	0.00107	CcSEcCtD
Trihexyphenidyl—Headache—Betamethasone—atopic dermatitis	7.73e-05	0.00106	CcSEcCtD
Trihexyphenidyl—Headache—Dexamethasone—atopic dermatitis	7.73e-05	0.00106	CcSEcCtD
Trihexyphenidyl—Asthenia—Prednisone—atopic dermatitis	7.71e-05	0.00106	CcSEcCtD
Trihexyphenidyl—Nausea—Betamethasone—atopic dermatitis	7.33e-05	0.00101	CcSEcCtD
Trihexyphenidyl—Nausea—Dexamethasone—atopic dermatitis	7.33e-05	0.00101	CcSEcCtD
Trihexyphenidyl—Dizziness—Prednisone—atopic dermatitis	7.11e-05	0.000976	CcSEcCtD
Trihexyphenidyl—Vomiting—Prednisone—atopic dermatitis	6.84e-05	0.000939	CcSEcCtD
Trihexyphenidyl—Rash—Prednisone—atopic dermatitis	6.78e-05	0.000931	CcSEcCtD
Trihexyphenidyl—Dermatitis—Prednisone—atopic dermatitis	6.77e-05	0.00093	CcSEcCtD
Trihexyphenidyl—Headache—Prednisone—atopic dermatitis	6.73e-05	0.000925	CcSEcCtD
Trihexyphenidyl—Nausea—Prednisone—atopic dermatitis	6.39e-05	0.000877	CcSEcCtD
Trihexyphenidyl—CHRM3—Signaling by GPCR—CCL17—atopic dermatitis	2.19e-05	0.00209	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR ligand binding—CCR5—atopic dermatitis	2.19e-05	0.00209	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—CCL17—atopic dermatitis	2.17e-05	0.00207	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CCL27—atopic dermatitis	2.15e-05	0.00205	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—CCR3—atopic dermatitis	2.15e-05	0.00204	CbGpPWpGaD
Trihexyphenidyl—CHRM2—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	2.11e-05	0.00201	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—NPS—atopic dermatitis	2.11e-05	0.00201	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—TAC1—atopic dermatitis	2.11e-05	0.00201	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—CXCR3—atopic dermatitis	2.07e-05	0.00197	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CCL27—atopic dermatitis	2.06e-05	0.00196	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—CCR3—atopic dermatitis	2.05e-05	0.00196	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	2.03e-05	0.00193	CbGpPWpGaD
Trihexyphenidyl—CHRM2—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	2.03e-05	0.00193	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	2.02e-05	0.00193	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—TAC1—atopic dermatitis	2.02e-05	0.00192	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—NPS—atopic dermatitis	2.02e-05	0.00192	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	2e-05	0.00191	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—CXCL10—atopic dermatitis	1.99e-05	0.0019	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—CXCL10—atopic dermatitis	1.99e-05	0.00189	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—CXCR3—atopic dermatitis	1.98e-05	0.00188	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—CXCL10—atopic dermatitis	1.97e-05	0.00187	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—IL5—atopic dermatitis	1.96e-05	0.00186	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CCL17—atopic dermatitis	1.93e-05	0.00184	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—TAC1—atopic dermatitis	1.91e-05	0.00182	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—NPS—atopic dermatitis	1.91e-05	0.00182	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—CXCR3—atopic dermatitis	1.88e-05	0.00179	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—IL5—atopic dermatitis	1.88e-05	0.00179	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CCL17—atopic dermatitis	1.85e-05	0.00176	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—TAC1—atopic dermatitis	1.83e-05	0.00174	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—NPS—atopic dermatitis	1.83e-05	0.00174	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.82e-05	0.00173	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—CXCR3—atopic dermatitis	1.8e-05	0.00171	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—IL5—atopic dermatitis	1.78e-05	0.00169	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—CCL11—atopic dermatitis	1.77e-05	0.00169	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—CCL11—atopic dermatitis	1.77e-05	0.00168	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—CCL11—atopic dermatitis	1.75e-05	0.00167	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—FCER2—atopic dermatitis	1.75e-05	0.00167	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—FCER2—atopic dermatitis	1.74e-05	0.00166	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.74e-05	0.00166	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—FCER2—atopic dermatitis	1.73e-05	0.00165	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—KIF3A—atopic dermatitis	1.72e-05	0.00164	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—CCL5—atopic dermatitis	1.71e-05	0.00163	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—CCL5—atopic dermatitis	1.71e-05	0.00163	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—IL5—atopic dermatitis	1.7e-05	0.00162	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—CCL5—atopic dermatitis	1.69e-05	0.00161	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—CXCL10—atopic dermatitis	1.67e-05	0.00159	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—GLB1—atopic dermatitis	1.65e-05	0.00157	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—KIF3A—atopic dermatitis	1.65e-05	0.00157	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CCL22—atopic dermatitis	1.63e-05	0.00155	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CCL22—atopic dermatitis	1.62e-05	0.00154	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CCL22—atopic dermatitis	1.61e-05	0.00153	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—CXCL10—atopic dermatitis	1.6e-05	0.00152	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—CCR3—atopic dermatitis	1.59e-05	0.00152	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—CCR3—atopic dermatitis	1.59e-05	0.00151	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—ADSL—atopic dermatitis	1.58e-05	0.00151	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—CCR3—atopic dermatitis	1.57e-05	0.0015	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CMA1—atopic dermatitis	1.55e-05	0.00148	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CCL11—atopic dermatitis	1.55e-05	0.00148	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—CCR5—atopic dermatitis	1.54e-05	0.00147	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—CCR5—atopic dermatitis	1.54e-05	0.00147	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Circadian rythm related genes—MAPK8—atopic dermatitis	1.54e-05	0.00146	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—CCR5—atopic dermatitis	1.52e-05	0.00145	CbGpPWpGaD
Trihexyphenidyl—CHRM2—G alpha (i) signalling events—CXCL8—atopic dermatitis	1.52e-05	0.00145	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—CXCL10—atopic dermatitis	1.52e-05	0.00144	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CCL11—atopic dermatitis	1.49e-05	0.00142	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CMA1—atopic dermatitis	1.49e-05	0.00142	CbGpPWpGaD
Trihexyphenidyl—CHRM2—SIDS Susceptibility Pathways—TNF—atopic dermatitis	1.47e-05	0.0014	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—STAT6—atopic dermatitis	1.46e-05	0.00139	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—CXCL10—atopic dermatitis	1.45e-05	0.00138	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CCL27—atopic dermatitis	1.45e-05	0.00138	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—CCR3—atopic dermatitis	1.45e-05	0.00138	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CCL27—atopic dermatitis	1.45e-05	0.00138	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—CCR3—atopic dermatitis	1.44e-05	0.00137	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—CCL5—atopic dermatitis	1.44e-05	0.00137	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CCL27—atopic dermatitis	1.43e-05	0.00136	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—CCR3—atopic dermatitis	1.43e-05	0.00136	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—TAC1—atopic dermatitis	1.42e-05	0.00135	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—NPS—atopic dermatitis	1.42e-05	0.00135	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—TAC1—atopic dermatitis	1.42e-05	0.00135	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—NPS—atopic dermatitis	1.42e-05	0.00135	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—NPS—atopic dermatitis	1.4e-05	0.00134	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—TAC1—atopic dermatitis	1.4e-05	0.00134	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—STAT6—atopic dermatitis	1.4e-05	0.00133	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—CXCR3—atopic dermatitis	1.39e-05	0.00133	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—CXCR3—atopic dermatitis	1.39e-05	0.00132	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR ligand binding—CXCL8—atopic dermatitis	1.39e-05	0.00132	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—CCL5—atopic dermatitis	1.38e-05	0.00131	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—CXCR3—atopic dermatitis	1.37e-05	0.00131	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR ligand binding—CXCL8—atopic dermatitis	1.33e-05	0.00126	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	1.32e-05	0.00126	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—IL5—atopic dermatitis	1.32e-05	0.00126	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—IL5—atopic dermatitis	1.32e-05	0.00125	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—CCL5—atopic dermatitis	1.31e-05	0.00124	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—IL5—atopic dermatitis	1.3e-05	0.00124	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CCL17—atopic dermatitis	1.3e-05	0.00124	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CCL17—atopic dermatitis	1.3e-05	0.00123	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—CCR5—atopic dermatitis	1.29e-05	0.00123	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—TAC1—atopic dermatitis	1.29e-05	0.00123	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—NPS—atopic dermatitis	1.29e-05	0.00123	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—TAC1—atopic dermatitis	1.29e-05	0.00122	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—NPS—atopic dermatitis	1.29e-05	0.00122	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CCL17—atopic dermatitis	1.28e-05	0.00122	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—NPS—atopic dermatitis	1.27e-05	0.00121	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—TAC1—atopic dermatitis	1.27e-05	0.00121	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CCR3—atopic dermatitis	1.27e-05	0.00121	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—CXCR3—atopic dermatitis	1.26e-05	0.0012	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—CXCR3—atopic dermatitis	1.26e-05	0.0012	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—CCL5—atopic dermatitis	1.25e-05	0.00119	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—CXCR3—atopic dermatitis	1.25e-05	0.00119	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—CCR5—atopic dermatitis	1.24e-05	0.00118	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.23e-05	0.00117	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.22e-05	0.00116	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CCR3—atopic dermatitis	1.21e-05	0.00116	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.21e-05	0.00115	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—IL5—atopic dermatitis	1.2e-05	0.00114	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—IL5—atopic dermatitis	1.2e-05	0.00114	CbGpPWpGaD
Trihexyphenidyl—CHRM2—SIDS Susceptibility Pathways—IL6—atopic dermatitis	1.19e-05	0.00113	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—IL5—atopic dermatitis	1.18e-05	0.00113	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—CCR5—atopic dermatitis	1.18e-05	0.00112	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—KIF3A—atopic dermatitis	1.16e-05	0.0011	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—KIF3A—atopic dermatitis	1.16e-05	0.0011	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—KIF3A—atopic dermatitis	1.14e-05	0.00109	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—NPS—atopic dermatitis	1.13e-05	0.00108	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—TAC1—atopic dermatitis	1.13e-05	0.00108	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—CCR5—atopic dermatitis	1.13e-05	0.00107	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—CXCL10—atopic dermatitis	1.13e-05	0.00107	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—CXCL10—atopic dermatitis	1.12e-05	0.00107	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—CXCL10—atopic dermatitis	1.11e-05	0.00106	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CXCR3—atopic dermatitis	1.11e-05	0.00106	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—NPS—atopic dermatitis	1.08e-05	0.00103	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—TAC1—atopic dermatitis	1.08e-05	0.00103	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CXCR3—atopic dermatitis	1.06e-05	0.00101	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—IL5—atopic dermatitis	1.05e-05	0.001	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CMA1—atopic dermatitis	1.05e-05	0.000999	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CCL11—atopic dermatitis	1.05e-05	0.000999	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CMA1—atopic dermatitis	1.05e-05	0.000995	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CCL11—atopic dermatitis	1.05e-05	0.000995	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CMA1—atopic dermatitis	1.03e-05	0.000986	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CCL11—atopic dermatitis	1.03e-05	0.000986	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—CXCL10—atopic dermatitis	1.02e-05	0.000974	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—CXCL10—atopic dermatitis	1.02e-05	0.00097	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—CXCL10—atopic dermatitis	1.01e-05	0.000961	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—IL5—atopic dermatitis	1.01e-05	0.000958	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—STAT6—atopic dermatitis	9.86e-06	0.000939	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—STAT6—atopic dermatitis	9.83e-06	0.000936	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Circadian rythm related genes—IL6—atopic dermatitis	9.82e-06	0.000935	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—STAT6—atopic dermatitis	9.73e-06	0.000927	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—CCL5—atopic dermatitis	9.69e-06	0.000923	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—CCL5—atopic dermatitis	9.66e-06	0.00092	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—CCL5—atopic dermatitis	9.57e-06	0.000911	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR ligand binding—CXCL8—atopic dermatitis	9.34e-06	0.000889	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR ligand binding—CXCL8—atopic dermatitis	9.31e-06	0.000887	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	9.3e-06	0.000886	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	9.27e-06	0.000883	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR ligand binding—CXCL8—atopic dermatitis	9.22e-06	0.000878	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CXCL10—atopic dermatitis	8.96e-06	0.000853	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—CCL5—atopic dermatitis	8.8e-06	0.000838	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—CCL5—atopic dermatitis	8.77e-06	0.000835	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—CCR5—atopic dermatitis	8.73e-06	0.000831	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—CCR5—atopic dermatitis	8.7e-06	0.000829	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—CCL5—atopic dermatitis	8.69e-06	0.000827	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—CCR5—atopic dermatitis	8.62e-06	0.000821	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CXCL10—atopic dermatitis	8.58e-06	0.000817	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CCR3—atopic dermatitis	8.55e-06	0.000814	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CCR3—atopic dermatitis	8.52e-06	0.000811	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CCR3—atopic dermatitis	8.44e-06	0.000804	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—CCR5—atopic dermatitis	7.93e-06	0.000755	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—CCR5—atopic dermatitis	7.9e-06	0.000753	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—CXCL8—atopic dermatitis	7.83e-06	0.000745	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—CCR5—atopic dermatitis	7.83e-06	0.000745	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CCL5—atopic dermatitis	7.71e-06	0.000734	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—TAC1—atopic dermatitis	7.62e-06	0.000726	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—NPS—atopic dermatitis	7.62e-06	0.000726	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—TAC1—atopic dermatitis	7.59e-06	0.000723	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—NPS—atopic dermatitis	7.59e-06	0.000723	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—TAC1—atopic dermatitis	7.52e-06	0.000716	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—NPS—atopic dermatitis	7.52e-06	0.000716	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—CXCL8—atopic dermatitis	7.5e-06	0.000714	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—IL2—atopic dermatitis	7.48e-06	0.000712	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CXCR3—atopic dermatitis	7.47e-06	0.000711	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CXCR3—atopic dermatitis	7.45e-06	0.000709	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CCL5—atopic dermatitis	7.38e-06	0.000703	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CXCR3—atopic dermatitis	7.37e-06	0.000702	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—IL2—atopic dermatitis	7.16e-06	0.000682	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—NGF—atopic dermatitis	7.14e-06	0.00068	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—CXCL8—atopic dermatitis	7.11e-06	0.000677	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—IL5—atopic dermatitis	7.08e-06	0.000674	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—IL5—atopic dermatitis	7.06e-06	0.000672	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—IL5—atopic dermatitis	6.99e-06	0.000666	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CCR5—atopic dermatitis	6.95e-06	0.000661	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—NGF—atopic dermatitis	6.84e-06	0.000651	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—CXCL8—atopic dermatitis	6.81e-06	0.000648	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—IL2—atopic dermatitis	6.79e-06	0.000647	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CCR5—atopic dermatitis	6.65e-06	0.000633	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—IL2—atopic dermatitis	6.51e-06	0.00062	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CXCL10—atopic dermatitis	6.04e-06	0.000575	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CXCL10—atopic dermatitis	6.02e-06	0.000573	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CXCL10—atopic dermatitis	5.96e-06	0.000568	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—NFKBIA—atopic dermatitis	5.89e-06	0.000561	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—NFKBIA—atopic dermatitis	5.64e-06	0.000537	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—PPARA—atopic dermatitis	5.35e-06	0.00051	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—CXCL8—atopic dermatitis	5.28e-06	0.000503	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—CXCL8—atopic dermatitis	5.26e-06	0.000501	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—CXCL8—atopic dermatitis	5.21e-06	0.000496	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CCL5—atopic dermatitis	5.2e-06	0.000495	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CCL5—atopic dermatitis	5.18e-06	0.000493	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CCL5—atopic dermatitis	5.13e-06	0.000489	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—IL2—atopic dermatitis	5.04e-06	0.00048	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—IL2—atopic dermatitis	5.03e-06	0.000479	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—IL2—atopic dermatitis	4.98e-06	0.000474	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—NGF—atopic dermatitis	4.81e-06	0.000458	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—NGF—atopic dermatitis	4.8e-06	0.000457	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—CXCL8—atopic dermatitis	4.79e-06	0.000456	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—CXCL8—atopic dermatitis	4.78e-06	0.000455	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—NGF—atopic dermatitis	4.75e-06	0.000453	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—CXCL8—atopic dermatitis	4.73e-06	0.000451	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CCR5—atopic dermatitis	4.68e-06	0.000446	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CCR5—atopic dermatitis	4.67e-06	0.000445	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CCR5—atopic dermatitis	4.62e-06	0.00044	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—IL2—atopic dermatitis	4.58e-06	0.000436	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—IL2—atopic dermatitis	4.57e-06	0.000435	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—IL2—atopic dermatitis	4.52e-06	0.000431	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CXCL8—atopic dermatitis	4.2e-06	0.0004	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CXCL8—atopic dermatitis	4.02e-06	0.000383	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—IL2—atopic dermatitis	4.01e-06	0.000382	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—IL6—atopic dermatitis	3.99e-06	0.00038	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—NFKBIA—atopic dermatitis	3.97e-06	0.000378	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—NFKBIA—atopic dermatitis	3.96e-06	0.000377	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—NFKBIA—atopic dermatitis	3.92e-06	0.000373	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—IL2—atopic dermatitis	3.84e-06	0.000366	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—IL6—atopic dermatitis	3.82e-06	0.000364	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—MAPK8—atopic dermatitis	3.69e-06	0.000352	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—MAPK8—atopic dermatitis	3.54e-06	0.000337	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CXCL8—atopic dermatitis	2.83e-06	0.00027	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CXCL8—atopic dermatitis	2.82e-06	0.000269	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CXCL8—atopic dermatitis	2.79e-06	0.000266	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—IL2—atopic dermatitis	2.71e-06	0.000258	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—IL2—atopic dermatitis	2.7e-06	0.000257	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—IL6—atopic dermatitis	2.69e-06	0.000256	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—IL6—atopic dermatitis	2.68e-06	0.000256	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—IL2—atopic dermatitis	2.67e-06	0.000254	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—IL6—atopic dermatitis	2.66e-06	0.000253	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—MAPK8—atopic dermatitis	2.49e-06	0.000237	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—MAPK8—atopic dermatitis	2.48e-06	0.000236	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—MAPK8—atopic dermatitis	2.46e-06	0.000234	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—IL6—atopic dermatitis	2.36e-06	0.000225	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—IL6—atopic dermatitis	2.26e-06	0.000215	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—IL6—atopic dermatitis	1.59e-06	0.000151	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—IL6—atopic dermatitis	1.59e-06	0.000151	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—IL6—atopic dermatitis	1.57e-06	0.00015	CbGpPWpGaD
